S23-091 Small-molecule control of membrane and secreted proteins via human proteases Researchers at Stanford have created a translational platform capable of controlling protein activity in cellular therapeutics using a human protease. Xiaojing Gao Carlos Aldrete
S21-461 Cell-type specific enzymatic degradation of pathological mucins Targeted protein degradation is an emerging strategy for the elimination of classically undruggable proteins. Mucins are known to be involved in tumor-progressive pathways but are difficult to target using small molecules and antibodies. Carolyn Bertozzi Kayvon Pedram Dayeon Shon Gabrielle Tender